Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ryzolt (abuse resistant formulation) / Endo
NCT04752384: Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients	Active, not recruiting	2	20	US	Buprenorphine, Belbuca, Probuphine, Buprenex, Tramadol, Ultram, Ryzolt, ConZip, Oral Mucositis (OM) Pain App, OM Pain App	Medical College of Wisconsin	Head and Neck Squamous Cell Carcinoma	04/24	09/25